Skip to content

We’re here to help.

Our compassionate and knowledgeable team is here to address your unique needs and provide the best possible care for your child’s neurodevelopmental journey.

Learn more

Teaching for a stronger community.

We are here to equip learners with the essentials skills needed to create positive change in the lives of people with developmental differences.

Learn more

Researching for a better tomorrow.

Our goal is to unlock discoveries that will revolutionize the lives of individuals with autism and other neurodevelopmental diagnoses.

Learn more

Researchers & Studies

Join A Study

We’re here to help.

Our compassionate and knowledgeable team is here to address your unique needs and provide the best possible care for your child’s neurodevelopmental journey.

Learn more

Teaching for a stronger community.

We are here to equip learners with the essentials skills needed to create positive change in the lives of people with developmental differences.

Learn more

Researching for a better tomorrow.

Our goal is to unlock discoveries that will revolutionize the lives of individuals with autism and other neurodevelopmental diagnoses.

Learn more

Thompson Center for Autism & Neurodevelopment

205 Portland Street, Columbia, MO 65211

573-884-6052

Researchers On The Go

MU Health Sciences Research Day – University of Missouri – November 2024

Tanvi Yadlapalli and Malori Chrisman

Autism Across the Life Span – University of Kansas – March 2025

Dr. Erin Andres and Nick Kanne

Jane Manson

Mizzou Show Me Research Week – University of Missouri – April 2025

Zoë Malik and Dr. Erin Andres

International Society for Autism Research (INSAR) – Seattle, WA – May 2025

Dr. Stephen Sheinkopf with Italia Camillone from Women and Infants Hospital of Rhode Island

Dr. David Beversdorf and Nanaan Nuraini

William Baskett

Making Sense of Autism Studies: Research Literacy Tips

In a world overflowing with headlines, health trends, and social media advice, it’s easy to feel overwhelmed by scientific claims, especially those related to autism. You might see a flashy news story touting a “breakthrough” therapy, or come across a study on Facebook that sounds too good—or too alarming—to be true.

Being research literate means knowing how to ask the right questions about science, and it’s more important than ever. As Nicole Takahashi, Research Core Director at the Thompson Center for Autism & Neurodevelopment, explains, “science literacy is no different than other types of media literacy.” Whether you’re reading a news article or a peer-reviewed journal, the key is to remain thoughtful, skeptical, and curious.

Before accepting a research claim at face value, consider the following points from the Thompson Center Research Core team.

Sample Size: Why A Few Isn’t Enough


If a study involves only a small number of participants, its findings may not be reliable. “You can’t make a lot of inferences from just a group of five, or even 100 in some cases,” Takahashi says. In general, larger sample sizes allow for more confidence that the findings apply to a broader population.

Amanda Moffitt Gunn, Research Specialist II at the Thompson Center, adds that a large, diverse sample helps researchers determine whether a result is generalizable. In other words, it helps determine whether it can be used to make predictions about people beyond those included in the study.

Small studies are also more prone to sample bias. As Moffitt Gunn notes, researchers may (consciously or not) select participants likely to produce expected outcomes, which can make results seem stronger than they actually are. For instance, if an autism study only includes participants with strong verbal skills, its conclusions may not truly apply to nonspeaking autistic individuals.

Methodology & Replication Matter


Reliable research should be transparent about its methodology. This includes how participants were selected, what tools were used, and how results were measured. If that information is missing or vague, it becomes difficult to assess the study’s credibility. “If a lot of important details are missing,” says Takahashi, “it makes me wonder, ‘Why aren’t they giving me all of the information?’”

While one well-conducted study can be informative, real confidence comes when independent researchers replicate the results using different methods. “You can be more confident in the findings if multiple, independent groups that were using slightly different techniques all drew the same conclusion,” Moffitt Gunn explains.

Watch for Correlation Confusion


Strong research clearly distinguishes between correlation and causation. Correlation means that two factors appear related. Causation means that one factor directly affects the other. A classic example? Ice cream sales and crime both increase in summer, but that doesn’t mean selling ice cream causes crime.

“Just because two things are related doesn’t mean that one causes the other. And even if it does, a correlation doesn’t show the direction of the causation,” says Moffitt Gunn.

This issue shows up frequently in autism research. For instance, autism symptoms often become noticeable around the same time children receive vaccinations. But that is also when many parents complete developmental screenings like the M-CHAT. “Parents may be alerted to symptoms that were already there because they were at a routine doctor’s appointment, where they also happened to receive a vaccination,” Moffitt Gunn explains.

Another example: children with autism are statistically more likely to have older fathers. That’s a correlation, not proof that paternal age causes autism.

What Do the Experts Think?


For those without scientific training, it can be difficult to determine whether a study’s methods and conclusions are valid. That’s where peer review becomes essential. Peer review is the process by which other experts evaluate a study before it is published, providing a critical quality check. If a claim does not reference a peer-reviewed journal, that’s a red flag.

Consider the Motives & Marketing


Sometimes, research is driven more by commercial interests than by scientific inquiry. Bailey Long, a Research Specialist I, notes that not all studies are neutral—especially when companies fund research supporting the products they sell.

Research Specialist I Jane Manson advises caution when a product is marketed with dramatic or exaggerated claims. “If there’s a claim that a product is a miracle, is going to fix all of your problems, and that’s why you should buy it, that should give you pause in any context,” they said.

Takahashi reminds us that catchy headlines rarely capture the full nuance of research. “I’m guilty just as much as anyone else is of seeing an enticing headline and saying, ‘I’ve only seen the headline, I haven’t had time to research it, but did you see this new thing?’ But I try to always have that caveat that it might not be what it seems.”

Don’t Confuse Popularity With Scientific Proof


Not every popular trend is backed by solid evidence. Weighted blankets, essential oils, or gluten-free diets might help some people, but they are not all supported by strong research. That doesn’t mean they must be dismissed entirely, but it is important to manage expectations and consult healthcare professionals.
As Moffitt Gunn points out, sometimes improvements result from unrelated changes. For instance, a child may appear to benefit from a casein-free diet not because the diet affects autism symptoms, but because the child was lactose intolerant and simply feels better. “If something works for one family, that’s great for them. But it doesn’t necessarily mean that we can use that as a basis to make recommendations to a large swath of people,” she says.

Stay Skeptical (Even of Things You Agree With)


“It’s good to keep a mindset of being skeptical,” says Dakota Fields, Research Specialist II. “Try to be mindful, even for sources you do trust—try not to take anything at face value. You don’t want to be susceptible to misinformation just because it aligns with something you already believe in.” Being research literate means asking tough questions and being willing to challenge your own assumptions.

The Bottom Line


You don’t need to be a scientist to think like one. With curiosity, caution, and a willingness to ask questions, anyone can become more confident in evaluating research claims. That confidence can help you make informed decisions.

Autism & Vaccines: Separating Fact from Fiction

By Dr. Benjamin Black, Developmental-Behavioral Pediatrician and Medical Director of the Thompson Center for Autism & Neurodevelopment

Vaccination remains one of the most effective public health interventions in modern medicine, yet persistent misinformation continues to link vaccines with autism spectrum disorder. As a multidisciplinary autism and neurodevelopmental center dedicated to evidence-based care and research, we believe it is crucial to address these misconceptions and reaffirm the overwhelming scientific consensus: vaccines do not cause autism.

The Origin of the Vaccine-Autism Myth


The claim that vaccines cause autism can be traced back to a now-retracted 1998 study published in The Lancet by Andrew Wakefield. The study suggested a link between the measles-mumps-rubella (MMR) vaccine and autism; however, it was based on a small sample size, lacked proper controls, and was found to be riddled with ethical and methodological flaws.

Subsequent investigations led to the study’s retraction, and Wakefield lost his medical license. Despite this, the misinformation took root, fueling vaccine hesitancy worldwide.

Scientific Evidence Disproving a Link


Over the past two decades, extensive research has been conducted to investigate any potential association between vaccines and autism. Large-scale studies, including those by the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and independent researchers, have consistently found no link between vaccines and autism.

For example, a landmark 2019 study conducted in Denmark followed over 650,000 children and found no increased risk of autism in those who received the MMR vaccine compared to those who did not. Similar studies worldwide have reinforced these findings, further discrediting the claim that vaccines contribute to autism diagnoses.

Understanding Autism’s True Origins


Autism is a neurodevelopmental condition with complex genetic and environmental influences. Advances in genetic research have identified hundreds of genes associated with autism, and studies indicate that autism begins in early brain development, often before birth. Environmental factors, such as prenatal exposures and complications during pregnancy, may contribute to autism risk, but vaccines are not among them.

The Dangers of Vaccine Misinformation


Misinformation about vaccines has real-world consequences. Decreased vaccination rates have led to outbreaks of preventable diseases, such as measles, which had been nearly eradicated in many countries. When vaccine uptake declines, vulnerable populations—including children with neurodevelopmental conditions—face increased risks of severe illness.

Our Commitment to Evidence-Based Care


As clinicians, researchers, and advocates for individuals with autism, our Center remains committed to disseminating accurate information. We encourage families to rely on reputable sources, such as the WHO and the American Academy of Pediatrics, when making health decisions.

Autism is a lifelong condition that requires compassion, understanding, and scientific inquiry. Ensuring that families receive accurate information about its causes—including dispelling harmful myths about vaccines—is essential to promoting both public health and the well-being of the autism community.

For more information, we invite you to explore our Center’s research initiatives and educational resources on autism and neurodevelopment. We remain committed to allocating our resources, expertise, and time for the betterment of our patients and their families and will continue to follow the science in researching the causes and best interventions for children with autism.

Family Resource Services at the Thompson Center

At the Thompson Center, our family navigators and social workers come together to create the Family Resource Services (FRS) team. The FRS team provides crucial assistance and support to individuals navigating the referral process, finding clinical services best suited for their needs, participating in the evaluation process, and coordinating care after receiving a diagnosis.  

The Family Resource Services team’s goal is to offer continuous support throughout a patient’s time at the Thompson Center, from initial referral through connection to community resources and discharge. Because the referral and scheduling process can be overwhelming, having a dedicated team to guide families reduces stress, and ensures the process runs smoothly.   

Family navigators are the front-line support for patients seeking autism and other evaluations. They are available to answer questions, assist with paperwork, and ensure that patients are assigned to the most appropriate appointment type for their specific needs. Once placed on an appointment waitlist, the team follows up with a scheduling call approximately two months before the projected appointment date. 

Family navigators not only improve scheduling and managing referrals for families but also play a key role in reducing wait times for evaluations and seeing more patients. During this process, family navigators ask important questions to ensure that the Thompson Center is the best fit for addressing the patient’s concerns and that they are scheduled for the most appropriate type. This proactive approach ensures that patients won’t end up waiting for services that aren’t the best match for their needs. Family navigators can match patients and families to services and providers that are a better fit for their needs.  

Support doesn’t end once an appointment is scheduled. When patients arrive at the center, our team of social workers continues to assist, answering any questions and bridging gaps in care. They also provide referrals for additional services and resources through other organizations. 

The Family Resource Services team is an integral part of the Thompson Center, contributing to both reducing wait times and providing continuous support for patients, families, and caregivers. 

April Events Calendar

April is World Autism Month and the Thompson Center has lots of events planned to celebrate! Keep track of all of our World Autism Month activities for patients, families, and our community with our April calendar.

Click here for a printable PDF

Thompson Center World Autism Month events:

Click here to browse all upcoming Thompson Center events

2024 Year In Review

Take a look back on all of the amazing things our team has accomplished and celebrated together this year!

2024 At A Glance

January

February

March

April

May

June

July

August

September

October

November

December

New Provider Spotlight: Isabella Steinbach, Genetic Counselor

Isabella Steinbach, M.S., CGC, is our new Genetics Counselor joining the Thompson Center’s medical team. Discover more about Isabella from our latest Q&A with her. 

What got you interested in working with autism and neurodevelopment?

My training in graduate school involved clinical rotations in a variety of specialties. Going into school, I was most interested in cancer genetics. While I did enjoy my rotations in cancer, I was surprised by how much I enjoyed my pediatric neurology and general pediatrics rotations. The combination of dedicated time, care coordination, and compassion that pediatrics providers have for their patients was exactly what I was looking for in my career. Neurodevelopmental conditions are complex, and genetics can add another daunting layer of complexity for a family. It is incredibly rewarding to educate and empower families in this setting. 

What is your educational background?

I went to Missouri S&T in Rolla and received my undergraduate degree in biology. I then went to graduate school at Indiana University and received my master’s degree in medical and molecular genetics. 

Where did you work before joining the Thompson Center team?

I worked at Liberty Hospital in the Kansas City area for 3 ½ years. At that job, I worked with adult patients primarily in hereditary cancer and cardiovascular genetics. 

What are you most looking forward to about your new role at the Thompson Center?

I’m looking forward to being involved in the collaborative atmosphere at the Thompson Center and helping families better understand the genetics of their child’s health concerns. 

When you’re not working, what do you enjoy doing?

I enjoy reading, baking, cooking, and spending time with my family. 

Driving Innovation Through Multisite Studies

Photo: Thompson Center Research Core Staff (Left to Right): Bailey Long, Jane Manson, Nicole Takahashi (Director), Amanda Moffitt Gunn, Katelyn Weber, Nick Kanne (not pictured: Dakota Fields)

This article is from the fall 2024 issue of DISCOVERY, the Thompson Center’s research newsletter.

To maximize efficiency and foster expertise, the Thompson Center has developed a unique research structure that supports our mission of supporting individuals and families impacted by autism and other neurodevelopmental diagnoses. Our centralized Research Core allows our dedicated faculty to work on a wide range of studies with professional support, ensuring that the complexities of autism are met with the utmost care. This structure, alongside our access to the Thompson Center clinic and partnerships with other clinics across the MU Health Care system, allows us to be a leader in large, multisite studies, which can offer invaluable benefits to our patients and their families.

Why Multisite Studies Matter


Large, multisite studies allow researchers to access a more diverse group of participants, making the results more reliable and applicable across a broader range of settings. A larger pool of participants means that we can analyze subgroups more effectively—whether by age, gender, or other factors—providing more personalized insights. For families, this means that the findings from these studies are more likely to reflect real-world experiences and can ultimately lead to better services and supports.

Let’s take a closer look at some of the impactful multisite studies happening at the Thompson Center.

EarliTec: Eye Tracking for Early Autism Diagnosis


One of the innovative projects currently underway at the Thompson Center is the EarliTec study, developed by EarliTec Diagnostics Inc. This study uses a tablet device called the EarliPoint Evaluation for Autism Spectrum Disorder. The device shows videos depicting social interactions and tracks what the child is attending to by measuring their eye movements. An algorithm analyzes the data, and calculates the likelihood of autism.

To validate the device, participants undergo cognitive or developmental testing conducted by trained staff. This comprehensive approach aims to create a valid, reliable, easy-to-use autism screening tool that can be applied across clinical settings.

Since joining the EarliTec study in 2023, the Thompson Center has recruited about 70% of the typically developing participants needed for the research. These participants also undergo developmental and IQ testing, and parents are notified if the results suggest the need for further evaluation.

Our team has also consulted on aspects like IQ test administration and case management, helping to guide best practices for other participating research sites.

SPARK: The Largest Genetic Study of Autism


Another large-scale project happening at the Thompson Center is SPARK, the world’s largest genetic study of autism. With more than 100,000 individuals with autism and 175,000 of their family members enrolled, SPARK aims to better understand the genetic causes of autism and to use this knowledge to inform therapies, treatments, and support systems.

SPARK’s broad participant base has allowed researchers to identify more than 100 genes linked to autism. Families identified to have specific genetic links to autism receive personalized reports, providing crucial insights for roughly 10% of the participants. Additionally, through SPARK Research Match, participants are connected with other relevant research opportunities.

The Thompson Center is in its ninth grant year for SPARK and was the top recruiter out of 17 clinical sites last year, contributing to the vast scale that allows researchers to identify patterns and subgroups in autism with more accuracy than smaller studies could.

The Early Years Study: Exploring the Earliest Signs of Autism


The Early Years Study, originally launched at Brown University, focuses on identifying early indicators of autism in infants. This study collects data from infants and their families, including recordings of infant cries, developmental milestones, temperament, and behaviors. The goal is to understand early markers of autism that could lead to earlier and more effective interventions.

As recruitment for the Early Years Study wraps up, researchers are preparing for the next phase of the project. Children whose screening results at age two indicate the possibility of autism will be invited to come to the Thompson Center for a comprehensive evaluation. The results of this testing will be given to families in order to support and find resources for their children. The results will also help the research team to identify a set of infant characteristics that predict the whether a child is likely to be diagnosed with autism.

Beyond its primary aims, the Early Years Study is also exploring several related research questions, such as the connection between parental autistic traits and the likelihood of autism in their children.

Many Sites, One Goal


The common goal of all research at the Thompson Center is to make discoveries that benefit neurodiverse individuals and families. Whether it’s developing an easy-to-use screening tool through the EarliTec study, unlocking genetic links through SPARK, or identifying early signs of autism in infants through the Early Years Study, we’re committed to driving research that will improve lives.

Researcher Spotlight: Dr. Kerri Nowell

This article is from the fall 2024 issue of DISCOVERY, the Thompson Center’s research newsletter.

Kerri Nowell, Ph.D., joined the Thompson Center health psychology team as a postdoctoral fellow in 2016. Dr. Nowell stayed on as a faculty member after the completion of her training and became the Director of Health Professions at the Thompson Center in May. She is an Associate Clinical Professor in the Department of Health Psychology in the University of Missouri College of Health Sciences. Dr. Nowell is the principal investigator on the EarliTec and SPARK studies at the Thompson Center.

Tell us about your educational background.

I earned my bachelors in psychology and pre-med with a minor in biology from the University of Texas at Arlington. Then, I completed my masters degree in school psychology at Sam Houston State University in Huntsville, TX. I got my Ph.D. in school psychology from the University of Houston.

How did you first get involved with autism research?

I worked for seven years as a school psychologist before taking a position at Baylor College of Medicine’s Texas Children’s Hospital in the Department of Genetics. While at Texas Children’s, I became a site supervisor for the Simons Simplex Collection (SSC), a national autism genetics study which had another site at the Thompson Center. Though I loved my work with youth identified with neurodevelopmental disorders in school, it was the SSC that solidified my specific interest in autism.

What are your research interests?

I’m a clinician researcher. My clinical work drives my research, and my research informs my clinical practice. Most of my research questions come from the work I do with families. I want to find ways to improve diagnostic processes in a way that best supports families, gives us the best data possible, reduces wait times, and removes barriers to healthcare access. Over time, I’ve become increasingly interested in strengths-based research questions and looking beyond the current medical model of autism.

What is the long-term goal of your research?

The medical model is important for making an autism diagnosis, because that’s how people get services and it helps people understand why they are the way they are. However, I think being able to incorporate strengths into clinical practice will ultimately lead to better outcomes for people with autism.

What is your favorite thing about working in this field?

The patients and families! The kids I get to work with are hilarious and so unique. It’s easy to say that everyone is unique, but getting to experience it every day is a privilege.